Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Application of Genetic Testing for CYP 450 Polymorphism to Predict Response to Clopidogrel Inpatient Undergoing PCI ; volume:02 ; number:02 ; year:2017 ; pages:019-023
Indian Journal of Cardiovascular Disease in Women WINCARS ; 02, Heft 02 (2017), 019-023
- Beteiligte Personen und Organisationen
-
Ram, V. Seetha
Lalita, N.
Jyotsna, Maddury
- DOI
-
10.1055/s-0038-1656404
- URN
-
urn:nbn:de:101:1-2018121608050597376530
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ram, V. Seetha
- Lalita, N.
- Jyotsna, Maddury
Ähnliche Objekte (12)
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Genetic determinants of platelet response to clopidogrel
A cosimulation analyzer to validate an SCI to PCI bridge design
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
PSB-Zielvereinbarungen (PCI)
Schmucktafel der P.C.I.
Hurd's PCI arbiter
Additional approaches to assess the Vietnam Provincial Competitiveness Index (PCI)
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
A novel AllGlo probe-quantitative PCR method for detecting single nucleotide polymorphism in CYP2C19 to evaluate the antiplatelet activity of clopidogrel
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Genetic determinants of platelet response to clopidogrel
A cosimulation analyzer to validate an SCI to PCI bridge design
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
PSB-Zielvereinbarungen (PCI)
Schmucktafel der P.C.I.
Hurd's PCI arbiter
Additional approaches to assess the Vietnam Provincial Competitiveness Index (PCI)
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
A novel AllGlo probe-quantitative PCR method for detecting single nucleotide polymorphism in CYP2C19 to evaluate the antiplatelet activity of clopidogrel
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Genetic determinants of platelet response to clopidogrel
A cosimulation analyzer to validate an SCI to PCI bridge design
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
A Novel Multiplex HRM Assay to Detect Clopidogrel Resistance
The clinical impact of CYP2C19 *2 and *3 polymorphism on Clopidogrel and cost analysis
PSB-Zielvereinbarungen (PCI)
Schmucktafel der P.C.I.
Hurd's PCI arbiter
Additional approaches to assess the Vietnam Provincial Competitiveness Index (PCI)
CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt